|
|
||||||||
1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland 1001, New Zealand; and 3 Peptide Research Laboratories, Tulane University Medical Center, New Orleans, Louisiana 70112-2699
This study assesses the structure-activity
relationships of the actions of amylin on bone. In fetal rat
osteoblasts, only intact amylin and amylin-(1
8) stimulated cell
proliferation (half-maximal concentrations 2.0 × 10
11 and 2.4 × 10
10 M, respectively).
Amylin-(8
37), COOH terminally deamidated amylin, reduced
amylin, and reduced amylin-(1
8) (reduction results in cleavage of the
disulfide bond) were without agonist effect but acted as antagonists to
the effects of both amylin and amylin-(1
8). Calcitonin gene-related
peptide-(8
37) also antagonized the effects of amylin and
amylin-(1
8) on osteoblasts but was substantially less potent in this
regard than amylin-(8
37). In contrast, inhibition of bone resorption
in neonatal mouse calvariae only occurred with the intact amylin
molecule and was not antagonized by any of these peptides. The rate of
catabolism of the peptides in calvarial cultures was not accelerated in
comparison with that of intact amylin. This dissociation of the actions
of amylin suggests that it acts through two separate receptors, one on
the osteoclast (possibly the calcitonin receptor) and a second on the
osteoblast.
amylin molecular fragments; bone formation; amylin peptide blockers; structure-activity relationships
This article has been cited by other articles:
![]() |
J. Cornish, K. E. Callon, U. Bava, M. Watson, X. Xu, J. M. Lin, V. A. Chan, A. B. Grey, D. Naot, C. M. Buchanan, et al. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E117 - E122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cornish, K. E. Callon, J. A. Gasser, U. Bava, E. M. Gardiner, D. H. Coy, G. J. S. Cooper, and I. R. Reid Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E730 - E735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cornish, K. E. Callon, C. Q.-X. Lin, C. L. Xiao, T. B. Mulvey, G. J. S. Cooper, and I. R. Reid Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E779 - E783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cornish, K. E. Callon, A. R. King, G. J. S. Cooper, and I. R. Reid Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E694 - E699. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |